Welcome to our dedicated page for Air Prods & Chems SEC filings (Ticker: APD), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Air Products & Chemicals, Inc. filings document financial results, governance matters and capital structure for a public industrial gases company. Form 8-K reports furnish quarterly and full-year earnings releases under Item 2.02 and report governance events under Item 5.02 and annual meeting vote results under Item 5.07. The filings identify registered securities, including APD common stock on the New York Stock Exchange and Euro notes due 2028, 2031, 2032, 2035 and 2037.
Definitive proxy materials describe board elections, shareholder voting matters, executive compensation, pay-versus-performance data, governance practices and annual meeting procedures. Air Products' regulatory disclosures cover operating results for its industrial gases business, board composition, shareholder votes and debt and equity securities relevant to its public-company status.
Jessica Graziano, a director of Air Products & Chemicals, Inc. (APD), reported a Section 16 transaction dated 09/30/2025. The filing shows acquisition of 156.6796 phantom deferred stock units under the company’s Deferred Compensation Program for Directors, granted under the Long-Term Incentive Plan. The units are payable in shares of common stock equal to the number of units, at a time elected by the reporting person, typically after board service ends, and may be paid in a lump sum or up to ten installments.
The filing lists a reference price of $270.48 and reports 2,183.889 shares beneficially owned following the transaction. The form is signed by an attorney-in-fact on behalf of the reporting person.
Andrew W. Evans, a director of Air Products & Chemicals, Inc. (APD), reported a Section 16 transaction dated 09/30/2025 in which he acquired 3.2558 phantom deferred stock units under the company’s Director Deferred Compensation/Long-Term Incentive plan. The filing shows these units are payable in shares of common stock equal to the number of units at a time elected by the reporting person, generally after Board service ends, and may be paid as a lump sum or in up to ten installments. The report lists a per-share-related figure of $270.48 and indicates the reporting person beneficially owned 495.2362 shares following the transaction, held directly.
Tonit M. Calaway, a director of Air Products & Chemicals, Inc. (APD), reported a transaction dated 09/30/2025 on Form 4 showing acquisition of Phantom deferred stock units under the company’s Deferred Compensation Program for Directors. The filing records an accrual of 15.2704 Units (listed as payable in common stock equal in number to the Units) with a listed value of $270.48 and shows 2,322.728 derivative securities beneficially owned following the transaction. The Units are payable in shares after board service ends and may be taken as a lump sum or up to ten installments as elected by the reporting person.
Howard I. Ungerleider, a director of Air Products & Chemicals, Inc. (APD), reported on Form 4 that on 09/01/2025 he acquired 226.5493 phantom deferred stock units under the company’s director Deferred Compensation Program. The units are convertible into an equal number of common shares and are payable after board service ends, either as a lump sum or in up to ten installments as previously elected. The report shows a reference price of $294.27 and lists 226.5493 shares beneficially owned following the transaction, held directly. The filing was signed on 09/02/2025 by Andrea I. Rennig as attorney-in-fact.
Matthew Lepore, EVP & General Counsel of Air Products & Chemicals, Inc. (APD), reported an acquisition of 3,471 shares of the company's common stock on 08/18/2025. The Form 4 shows the transaction coded as an acquisition with a price listed as $0.0000, and states 3,471 shares are beneficially owned following the reported transaction, held directly. The filing is signed by Andrea I. Rennig as attorney-in-fact on 08/20/2025. No derivative securities or additional transactions are reported and the form does not include further context such as the reason for the $0.0000 price (e.g., grant, gift, or correction) or any change in reporting status.
On 08/18/2025 Matthew Lepore, identified as EVP & General Counsel of Air Products & Chemicals, Inc. (APD), filed an initial Form 3 reporting his relationship to the issuer. The filing states no securities are beneficially owned by the reporting person. The form was signed by Andrea I. Rennig as Attorney in Fact on 08/20/2025.
Air Products & Chemicals, Inc. reported the election of Mr. Ungerleider as a director and noted his compensation will follow the company’s standard non-employee director arrangements described in the definitive proxy statement for the 2025 annual meeting of shareholders. The company states there are no arrangements or understandings between Mr. Ungerleider and any other person related to his election and that neither he nor immediate family members are parties to transactions that would require reporting under Item 404(a) of Regulation S-K. The notice references a press release dated August 20, 2025 and the filing includes an interactive data cover page embedded in the Inline XBRL document. The report is signed by Matthew Lepore, Executive Vice President, General Counsel and Secretary.
Capital Research Global Investors reports beneficial ownership of 11,494,745 shares of Air Products and Chemicals, representing 5.2% of the 222,544,214 shares the filer believes to be outstanding. The filing shows CRGI has sole voting power over 11,492,856 shares and sole dispositive power over 11,494,745 shares, with no shared voting or dispositive power reported.
The disclosure describes CRGI as a division of Capital Research and Management Company together with named investment management affiliates and states the securities are held in the ordinary course of business and not to change or influence control of the issuer.
Air Products & Chemicals, Inc. (APD) – Form 4 insider transaction: Executive Vice President & Chief HR Officer Victoria Brifo reported an open-market sale (Code “S”) of 1,359 common shares on 08/05/2025 at $292.38 per share. After the sale, Brifo directly owns 8,686 shares and indirectly holds 84 shares through the company’s Retirement Savings Plan (RSP). No derivative security transactions were reported. The filing is made solely by the individual insider and does not amend prior reports.